Citation Tools

Download PDFPDF

Original research
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy

Download to a citation manager

Cite this article as:
Lopes JE, Fisher JL, Flick HL, et al
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy